Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on: April 09,2024

Deadly cancers show early, detectable differences from benign tumors

by Duke University Medical CenterCredit: CC0 Public DomainDo metastatic cancer tumors "break bad" or are they "born bad"?This question is an essential mystery incancer&n

Updated on:April 09,2024

Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia

by Case Western Reserve University'If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatme

Updated on: June 15,2024

Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia

by Case Western Reserve University'If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatme

Updated on:June 15,2024

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on: January 02,2024

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on:January 02,2024

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on: February 18,2024

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on:February 18,2024

Metastasis enablers: Findings could unlock new ovarian cancer treatments

by Tom Ziemer,University of Wisconsin-MadisonBiomedical engineering professor Pam Kreeger and other lab members have teased out how one type of immune cells helps cancer cells attach in the peri

Updated on: April 01,2024

Metastasis enablers: Findings could unlock new ovarian cancer treatments

by Tom Ziemer,University of Wisconsin-MadisonBiomedical engineering professor Pam Kreeger and other lab members have teased out how one type of immune cells helps cancer cells attach in the peri

Updated on:April 01,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on: January 02,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on:January 02,2024

Researchers first to develop comprehensive models of 'seeds and soil' as a means to combat breast cancer metastasis

by Virginia Commonwealth UniversityFrom left to right: Mohammad Alzubi, Chuck Harrell, Ph.D., and Tia Turner. Credit: VCU Massey Cancer CenterScientists at VCU Massey Cancer Center have identifie

Updated on: June 06,2024

Researchers first to develop comprehensive models of 'seeds and soil' as a means to combat breast cancer metastasis

by Virginia Commonwealth UniversityFrom left to right: Mohammad Alzubi, Chuck Harrell, Ph.D., and Tia Turner. Credit: VCU Massey Cancer CenterScientists at VCU Massey Cancer Center have identifie

Updated on:June 06,2024

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on: December 28,2023

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on:December 28,2023

Examining how some cancer cells cheat treatment-induced cell death

by St. Jude Children's Research HospitalGraphic abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.07.025Scientists at St. Jude Children's Research Hospital have identified

Updated on: January 30,2024

Examining how some cancer cells cheat treatment-induced cell death

by St. Jude Children's Research HospitalGraphic abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.07.025Scientists at St. Jude Children's Research Hospital have identified

Updated on:January 30,2024

Study unveils molecular pathways followed by metastatic cancer cells

by Baylor College of MedicineCredit: Unsplash/CC0 Public DomainMetastasis, the process by which cancer cells leave the primary tumor and spread to other tissues to seed new cancerous growth, caus

Updated on: February 01,2024

Study unveils molecular pathways followed by metastatic cancer cells

by Baylor College of MedicineCredit: Unsplash/CC0 Public DomainMetastasis, the process by which cancer cells leave the primary tumor and spread to other tissues to seed new cancerous growth, caus

Updated on:February 01,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on: March 09,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on:March 09,2024

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Updated on: January 22,2024

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Updated on:January 22,2024